EP Patent
EP3773681A1 — Conjugates
Assigned to Ascendis Pharma AS · Expires 2021-02-17 · 5y expired
What this patent protects
The present invention relates to a conjugate comprising a moiety of formula (I) or to conjugates of formula (I') and to pharmaceutical compositions comprising such conjugates.
USPTO Abstract
The present invention relates to a conjugate comprising a moiety of formula (I) or to conjugates of formula (I') and to pharmaceutical compositions comprising such conjugates.
Drugs covered by this patent
- Yorvipath (PALOPEGTERIPARATIDE) · Ascendis Pharma Bone
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.